PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$1.05B
1-Year Est. Return
89.76%
This Fund
S&P 500
1 Year Est. Return
+89.76%
AUM
$1.05B
AUM Growth
+$140M
(+15%)
Holding
111
Top Buys
| 1 | +$28.6M | |
| 2 | +$26.9M | |
| 3 | +$15.4M | |
| 4 |
Waters Corp
WAT
|
+$15.4M |
| 5 |
Mettler-Toledo International
MTD
|
+$15.3M |
Top Sells
| 1 | +$17.7M | |
| 2 | +$15.5M | |
| 3 | +$11.4M | |
| 4 |
Castle Biosciences
CSTL
|
+$10.5M |
| 5 |
Viridian Therapeutics
VRDN
|
+$10M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Boston Scientific
BSX
$102B
| $47.7M | 4.54% |
500,529
+66,152
|
|
||
2
Insulet
PODD
$16.6B
| $40M | 3.81% |
140,860
+24,622
|
|
||
3
DexCom
DXCM
$25.1B
| $39M | 3.71% |
587,475
+415,847
|
|
||
4
Stryker
SYK
$129B
| $37.1M | 3.53% |
105,472
+41,364
|
|
||
5
CVS Health
CVS
$96.8B
| $35.7M | 3.4% |
450,212
+70,726
|
|
||
6
McKesson
MCK
$116B
| $29.8M | 2.84% |
36,355
+7,813
|
|
||
7
KalVista Pharmaceuticals
KALV
$878M
| $28.6M | 2.72% |
1,768,508
+33,505
|
|
||
|
MBX
8
MBX Biosciences
MBX
$1.26B
| $27.9M | 2.66% |
885,639
+112,335
|
|
||
9
Kiniksa Pharmaceuticals
KNSA
$3.53B
| $27.4M | 2.61% |
665,208
-6,384
|
|
||
10
Masimo
MASI
$9.16B
| $26M | 2.48% |
+200,000
|
|
||
11
LivaNova
LIVN
$3.24B
| $25.3M | 2.41% |
410,912
+135,101
|
|
||
12
Terns Pharmaceuticals
TERN
$4.81B
| $25.1M | 2.39% |
620,877
-313,883
|
|
||
|
13
Viridian Therapeutics
VRDN
$2.9B
| $24.5M | 2.33% |
788,076
-366,411
|
|
||
14
Arcus Biosciences
RCUS
$2.85B
| $23.1M | 2.2% |
968,602
+315,922
|
|
||
|
UPB
15
Upstream Bio Inc
UPB
$510M
| $22.7M | 2.16% |
834,559
-8,943
|
|
||
16
Qiagen
QGEN
$8.47B
| $22.2M | 2.12% |
494,351
-5,808
|
|
||
17
Amicus Therapeutics
FOLD
$4.51B
| $21.2M | 2.02% |
1,487,283
-200,035
|
|
||
18
EyePoint Inc
EYPT
$1.17B
| $19.9M | 1.89% |
+1,088,033
|
|
||
19
Alnylam Pharmaceuticals
ALNY
$42.1B
| $19M | 1.81% |
47,703
-39,987
|
|
||
20
Neurocrine Biosciences
NBIX
$12.8B
| $16.3M | 1.55% |
114,712
-27,110
|
|
||
|
21
Waters Corp
WAT
$27.8B
| $15.9M | 1.52% |
+41,899
|
|
||
|
22
Mettler-Toledo International
MTD
$23.7B
| $15.3M | 1.46% |
+10,988
|
|
||
23
Mineralys Therapeutics
MLYS
$2.14B
| $14.9M | 1.42% |
410,249
-45,274
|
|
||
24
Stoke Therapeutics
STOK
$2.08B
| $13.7M | 1.3% |
430,155
+180,155
|
|
||
25
Agilent Technologies
A
$31.5B
| $13.6M | 1.3% |
+100,000
|
|